Immunowake is a biotechnology company that focuses on identifying new therapies for patients who do not respond to existing immunotherapies.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Birmingham
State: Alabama
Zip:
Country: United States
Immunowake is a biotechnology company that focuses on identifying new therapies for patients who do not respond to existing immunotherapies. Immunotherapy involves harnessing the body’s immune system to identify and kill cancer cells in the same way pathogens are identified and targeted. Recent breakthroughs in cancer immunotherapy have demonstrated that powerful anti-tumor responses can be achieved by activating antigen-specific T-cells.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2019 | Seed Round | $3M | 5/2022 | Series A | 4 | $20M |
HEDA Ventures Hyfinity Investments Lapam Capital South China Venture Capital HEDA Ventures Hyfinity Investments Lapam Capital South China Venture Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|